State Street Corp Cns Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$0.26 - $1.05 $430 - $1,739
1,657 Added 9.21%
19,645 $7,000
Q2 2021

Aug 16, 2021
BUY
$1.71 - $2.42 $30,759 - $43,530
17,988 New
17,988 $35,000

Others Institutions Holding CNSP

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About CNS Pharmaceuticals, Inc.

CNSP Quotes by TradingView
  • Ticker CNSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,032,500
  • Market Cap $4.4M
  • Description
  • CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....
More about CNSP
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email